Changes observed in diabetic retinopathy: eight-year follow-up of a Spanish population

The British Journal of Ophthalmology
Pedro Romero-ArocaNuria Soler

Abstract

To determine the changes in the incidence of diabetic retinopathy (DR), diabetic macular oedema (DMO) and their risk factors in a population-based study of patients with diabetes mellitus (DM) referred to our 16 Primary Health Care Areas (HCAs). Prospective population-based study of a total of 15 396 Caucasian patients with DM, who represent 86.53% of the total patients with DM in our HCAs, were studied over an 8-year follow-up period. All patients were screened with a mean follow-up of 3.18±1.11 times for each patient over the 8 years. The yearly mean value of any DR was 8.37±2.19% (8.09%-8.99%); of advanced DR yearly mean value of 0.46±0.22% (0.03-0.78); and of DMO a yearly mean value of 2.19±0.18% (2%-2.49%). A clear increase was observed in the last 3 years, any DR increased from 8.09% in 2007 to 8.99% in 2014, and DMO from 2% in 2007 to 2.49% in 2014. These increases were more evident in some age groups. For patients with any DR aged 41-50 and 51-60 and for patients with advanced DR aged 41-50, 51-60 and 61-70, the increase was more marked, related to an increase in HbA1c values or to patients treated with insulin. An increase in the incidence of DR and DMO was observed, especially in the younger patients aged between 31 a...Continue Reading

References

Sep 18, 2003·Ophthalmology·C P WilkinsonUNKNOWN Global Diabetic Retinopathy Project Group
Apr 2, 2005·Archivos de la Sociedad Española de Oftalmología·E Santos BuesoJ Fernández Perianes
Nov 10, 2009·Diabetes Research and Clinical Practice·J E ShawP Z Zimmet
Mar 2, 2010·Diabetes Research and Clinical Practice·Pedro RomeroMarc Baget
Jun 12, 2010·Diabetic Medicine : a Journal of the British Diabetic Association·S Jones, R T Edwards
Oct 29, 2010·Diabetes Care·Pedro Romero-Aroca
Dec 31, 2010·Clinical Ophthalmology·Pedro Romero-ArocaAngel Bautista-Perez
Dec 27, 2011·Diabetologia·M B SasongkoJ J Wang
Feb 4, 2012·Diabetes Care·Joanne W Y YauUNKNOWN Meta-Analysis for Eye Disease (META-EYE) Study Group
Mar 26, 2013·Diabetes Research and Clinical Practice·Leonor Guariguata
Mar 7, 2014·The British Journal of Ophthalmology·H C LookerUNKNOWN Scottish Diabetic Retinopathy Collaborative
Mar 26, 2014·The British Journal of Ophthalmology·Rupert R A BourneUNKNOWN Vision Loss Expert Group of the Global Burden of Disease Study
Jul 29, 2015·Investigative Ophthalmology & Visual Science·Ryan Eyn Kidd ManEcosse L Lamoureux

❮ Previous
Next ❯

Citations

Aug 6, 2016·BMC Ophthalmology·Pedro Romero-ArocaDomenec Puig
Oct 21, 2016·Journal of Diabetes Research·Pedro Romero-ArocaRaquel Verges
Feb 22, 2018·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Pedro Romero-ArocaDomenec Puig
Mar 9, 2017·The British Journal of Ophthalmology·Pedro Romero-ArocaNuria Soler
Oct 9, 2018·European Journal of Ophthalmology·Rodrigo Abreu-GonzalezMaría I Lopez-Galvez
Apr 2, 2020·International Journal of Molecular Sciences·Shou OosukaTsunehiko Ikeda
Aug 3, 2019·The International Journal of Health Planning and Management·Fei QinRong Shi
Mar 30, 2017·Acta Diabetologica·Ana I Arroba, Ángela M Valverde
Feb 27, 2020·PharmacoEconomics Open·Fernando de Andrés-NogalesJosé Martínez-Olmos
May 19, 2021·Translational Vision Science & Technology·Pedro Romero-ArocaMarc Baget-Bernaldiz

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.